Publication | Open Access
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
266
Citations
26
References
2022
Year
Orchard Therapeutics, Fondazione Telethon, and GlaxoSmithKline.
| Year | Citations | |
|---|---|---|
Page 1
Page 1